Childhood cancers trials in Belgium
84 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Where
- Leuven
- Age
- 12 years and over
- People
- 359 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00 - Phase 2Taking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Gent, Leuven, Sint-Lambrechts-Woluwe
- Age
- 1 year to 17 years
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - Phase 3Taking peopleCHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
- Where
- Brussels, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- Up to 64 years
- People
- 675 worldwide
- Run by
- Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-504999-25-00 · EU 2023-504999-25-00 - Phase 2Enrolling by invitationLong-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
- Where
- Leuven
- People
- 1,500 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT05041309 · EU 2023-507041-28-00 - Phase 1/2Taking peopleA Phase 1/2 study of Enzomenib (DSP-5336) in Patients with Acute leukemia
- Where
- Antwerp, Gent, Leuven, Roeselare
- People
- 94 worldwide
- Run by
- Sumitomo Pharma America Inc.
See details and how to join2022-502741-10-00 · EU 2022-502741-10-00 - No phaseTaking peoplePain and Sleep Disturbances in Children Living Beyond Cancer: A Case-Control Study
- Where
- Brussels, Jette
- Age
- 6 years to 12 years
- People
- 76
- Run by
- Vrije Universiteit Brussel
See details and how to joinNCT07120646 - Phase 3Taking peopleAn international trial for children with atypical teratoid/rhabdoid tumours (ATRT)
- Where
- Brussels, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- Up to 17 years
- People
- 301 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501456-28-00 · EU 2022-501456-28-00 - Phase 3Taking peopleSIOP RANDOMET 2017
- Where
- Brussels, Edegem, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- Up to 17 years
- People
- 409 worldwide
- Run by
- GPOH gGmbH
See details and how to join2023-508926-91-00 · EU 2023-508926-91-00 - Phase 3Taking peopleSIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
- Where
- Brussels, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- Up to 64 years
- People
- 311 worldwide
- Run by
- The University Of Birmingham
See details and how to join2024-510578-25-00 · EU 2024-510578-25-00 - Phase 2/3Taking peopleAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Brussels, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- 1 month to 18 years
- People
- 1,800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - No phaseTaking peopleRegister With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
- Where
- Leuven
- People
- 125
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT01617382 - No phaseTaking peopleCerebellar Mutism Syndrome Study
- Where
- Leuven
- Age
- Up to 18 years
- People
- 2,000 worldwide
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT02300766 - No phaseTaking peopleAMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE)
- Where
- Antwerp, Brussels, Leuven, Liège, Montegnée
- Age
- 3 years to 14 years
- People
- 275 worldwide
- Run by
- Erasme University Hospital
See details and how to joinNCT02595255 - Phase 3Taking peopleA Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
- Where
- Brussels, Edegem, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- 0 years to 45 years
- People
- 6,430 worldwide
- Run by
- Mats Heyman
See details and how to joinNCT04307576 · EU 2022-501050-11-01 - Phase 2Taking peopleA Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Where
- Brussels, Ghent
- Age
- 1 year to 39 years
- People
- 105 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05999994 - No phaseTaking peopleHealth Effects of CArdiac FluoRoscopy and MOderN RadIotherapy in PediatriCs - Radiotherapy
- Where
- Leuven
- Age
- Up to 22 years
- People
- 2,670 worldwide
- Run by
- Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT04746729 - No phaseTaking peopleSecuring Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults
- Where
- Antwerp, Brussels, Ghent, Leuven, Liège
- Age
- 0 years to 25 years
- People
- 1,600
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT07727694 - Phase 1Taking peopleA Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Gent
- Age
- Up to 17 years
- People
- 18 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2024-520125-36-00 · EU 2024-520125-36-00 - Phase 3Taking peopleBrentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Where
- Antwerp, Edegem, Leuven, Namur, Roeselare
- Age
- 16 years to 69 years
- People
- 1,042 worldwide
- Run by
- University College, London
See details and how to joinNCT04685616 · EU 2022-500031-37-00 - No phaseTaking peopleSPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
- Where
- Aalst, Antwerp, Brussels, Ghent, Haine-Saint-Paul, Leuven, Liège, Namur, Turnhout, Yvoir
- Age
- 12 years and over
- People
- 4,975 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT02834884 - Phase 2/3Taking peopleSIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma
- Where
- Brussels, Edegem, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- Up to 64 years
- People
- 894 worldwide
- Run by
- Centre Leon Berard
See details and how to joinNCT02265770 · EU 2024-512222-28-00 - Phase 1/2Taking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Leuven
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseEnrolling by invitationComparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
- Where
- Leuven
- Age
- 28 days and over
- People
- 1,600
- Run by
- prof. dr. Koen Van Laere
See details and how to joinNCT07595666 - Phase 3Taking peopleInternational Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
- Where
- Brussels, Edegem, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- Up to 18 years
- People
- 683 worldwide
- Run by
- University Hospital Muenster
See details and how to joinNCT04043494 · EU 2023-508101-24-00 - Phase 1/2Taking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Antwerp, Ghent, Leuven, Roeselare
- Age
- 12 years and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555